The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
437
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITYBDB
Chugai Seiyaku Kabushiki Kaisha
217
Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activityBDB
Terns Pharmaceuticals
186
Substituted pyrazoles showing serotonin 5-HT receptor activityBDB
Sumitomo Pharma
4
METHODS AND COMPOSITIONS COMPRISING A BRAF INHIBITOR AND A PD-1 BINDING ANTAGONISTBDB
Hoffmann-La Roche
91
MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOFBDB
Children'S Hospital Medical Center
47
ATR INHIBITORS AND USES THEREOFBDB
Antengene Discovery
85
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsBDB
H. Lundbeck
41
Inhibitors of RETBDB
Blueprint Medicines
16
Neuroprotective agents for treatment of neurodegenerative diseasesBDB
Wayne State University
23
Compositions and methods for treating KIT- and PDGFRA-mediated diseasesBDB
Blueprint Medicines
16
Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity.BDB
Agri Ibrahim Cecen University
17
Discovery of Potent and Muscle Selective Androgen Receptor Modulators through Scaffold Modifications.BDB
Bristol Myers Squibb